Know Cancer

or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Carcinoma, Renal Cell, Kidney Neoplasms

Thank you

Trial Information


Inclusion Criteria:



- Newly diagnosed metastatic renal cell carcinoma

- Suitable for nephrectomy

Exclusion Criteria:

- Prior chemotherapy, biological therapy or radiation therapy for renal cell carcinoma
or within the last 3 years for any other cancer

- Significant cardiac event within 3 months of entry

- Any history of coronary angioplasty or history of myocardial infarction

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

D2820C00018

NCT ID:

NCT00065572

Start Date:

August 2003

Completion Date:

February 2004

Related Keywords:

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Kidney Cancer
  • Metastatic
  • Newly diagnosed renal cell carcinoma
  • Neoplasms
  • Carcinoma
  • Carcinoma, Renal Cell
  • Kidney Neoplasms

Name

Location

Research SiteAnaheim, California  
Research SiteLewes, Delaware  
Research SiteBoca Raton, Florida  
Research SiteArlington Heights, Illinois  
Research SiteBloomington, Indiana  
Research SiteBaltimore, Maryland  
Research SiteBranson, Missouri  
Research SiteHooksett, New Hampshire  
Research SiteBelleville, New Jersey  
Research SiteAlbany, New York  
Research SiteAkron, Ohio  
Research SiteBend, Oregon  
Research SiteAllentown, Pennsylvania  
Research SiteChattanooga, Tennessee  
Research SiteIvins, Utah